Assessment of Prasugrel Antiplatelet P2Y12 Receptor Therapy in a Clopidogrel Nonresponder

被引：0
|
作者：
Ha, Thanh [1 ]
Nathan, Sandeep [2 ]
Mikrut, Krzysztof [1 ]
Miller, Jonathan L. [1 ]
机构：
[1] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
来源：
AMERICAN JOURNAL OF CLINICAL PATHOLOGY | 2010年 / 134卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
77
引用
收藏
页码：509 / 510
页数：2
相关论文
共 50 条
  • [21] Insufficient P2Y12 receptor occupancy by clopidogrel and stent thrombosis
    Gurbel, PA
    Bliden, KP
    Tantry, US
    CIRCULATION, 2005, 112 (17) : U749 - U749
  • [22] Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor
    Sun, Michelle T.
    Huang, Sonia
    Wiviott, Stephen D.
    Antman, Elliot M.
    Roe, Matthew T.
    Ohman, E. Magnus
    Neely, Megan
    Wallentin, Lars
    Wong, Christopher X.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (08): : 1280 - 1283
  • [23] P2Y12, a new platelet ADP receptor, target of clopidogrel
    Savi, P
    Labouret, C
    Delesque, N
    Guette, F
    Lupker, J
    Herbert, JM
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 283 (02) : 379 - 383
  • [24] AZD6140.: Antiplatelet therapy, P2Y12 (P2T) receptor antagonist
    Owen, R. T.
    Serradell, N.
    Bolos, J.
    DRUGS OF THE FUTURE, 2007, 32 (10) : 845 - 853
  • [25] CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY
    Ueno, Masafumi
    Ferreiro, Jose Luis
    Dharmashankar, Kodlipet
    Capranzano, Piera
    Capodanno, Davide
    Darlington, Andrew
    Bhaloo, Desai
    Charlton, Ronald
    Box, Lyndon
    Zenni, Martin
    Guzman, Luis
    Bass, Theodore
    Angiolillo, Dominick J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [26] Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease
    Yan-Jiao Zhang
    Dong-Jie Li
    Zhong-Yi Li
    Xiao-Lei Hu
    He Li
    Qi-Lin Ma
    Xiao-Ping Chen
    BMC Cardiovascular Disorders, 22
  • [27] Influence of genetic polymorphisms in P2Y12 receptor signaling pathway on antiplatelet response to clopidogrel in coronary heart disease
    Zhang, Yan-Jiao
    Li, Dong-Jie
    Li, Zhong-Yi
    Hu, Xiao-Lei
    Li, He
    Ma, Qi-Lin
    Chen, Xiao-Ping
    BMC CARDIOVASCULAR DISORDERS, 2022, 22 (01)
  • [28] Clopidogrel and prasugrel prolong primary hemostasis in the mouse beyond levels associated with P2Y12 inhibition
    Andre, P.
    DeGuzman, F.
    Mills, S.
    Pak, Y.
    Inagaki, M.
    Pandey, A.
    Hollenbach, S.
    Phillips, D.
    Conley, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 86 - 86
  • [29] Partial P2Y12 receptor blockade by clopidogrel may not be overcome by increasing the clopidogrel dose
    Judge, H.
    Buckland, R.
    Crosdale, D.
    Storey, R. F.
    EUROPEAN HEART JOURNAL, 2005, 26 : 487 - 487
  • [30] P2Y12 gene polymorphisms and the antiplatelet effect of a 600 mg loading dose of clopidogrel
    Gorchakova, O
    von Beckerath, N
    Koch, W
    Mocz, A
    Joost, A
    Schömig, A
    Kastrati, A
    EUROPEAN HEART JOURNAL, 2004, 25 : 238 - 238
12345